208 related articles for article (PubMed ID: 11350186)
1. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation.
Westphal V; Kjaergaard S; Davis JA; Peterson SM; Skovby F; Freeze HH
Mol Genet Metab; 2001 May; 73(1):77-85. PubMed ID: 11350186
[TBL] [Abstract][Full Text] [Related]
2. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
Schollen E; Dorland L; de Koning TJ; Van Diggelen OP; Huijmans JG; Marquardt T; Babovic-Vuksanovic D; Patterson M; Imtiaz F; Winchester B; Adamowicz M; Pronicka E; Freeze H; Matthijs G
Hum Mutat; 2000 Sep; 16(3):247-52. PubMed ID: 10980531
[TBL] [Abstract][Full Text] [Related]
3. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.
de Koning TJ; Dorland L; van Diggelen OP; Boonman AM; de Jong GJ; van Noort WL; De Schryver J; Duran M; van den Berg IE; Gerwig GJ; Berger R; Poll-The BT
Biochem Biophys Res Commun; 1998 Apr; 245(1):38-42. PubMed ID: 9535779
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption.
Helander A; Jaeken J; Matthijs G; Eggertsen G
Clin Chim Acta; 2014 Apr; 431():15-8. PubMed ID: 24508628
[TBL] [Abstract][Full Text] [Related]
5. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
Niehues R; Hasilik M; Alton G; Körner C; Schiebe-Sukumar M; Koch HG; Zimmer KP; Wu R; Harms E; Reiter K; von Figura K; Freeze HH; Harms HK; Marquardt T
J Clin Invest; 1998 Apr; 101(7):1414-20. PubMed ID: 9525984
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnosis of congenital disorders of glycosylation].
Vuillaumier-Barrot S
Ann Biol Clin (Paris); 2005; 63(2):135-43. PubMed ID: 15771971
[TBL] [Abstract][Full Text] [Related]
8. Successful liver transplantation and long-term follow-up in a patient with MPI-CDG.
Janssen MC; de Kleine RH; van den Berg AP; Heijdra Y; van Scherpenzeel M; Lefeber DJ; Morava E
Pediatrics; 2014 Jul; 134(1):e279-83. PubMed ID: 24982104
[TBL] [Abstract][Full Text] [Related]
9. Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency.
Harms HK; Zimmer KP; Kurnik K; Bertele-Harms RM; Weidinger S; Reiter K
Acta Paediatr; 2002; 91(10):1065-72. PubMed ID: 12434892
[TBL] [Abstract][Full Text] [Related]
10. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.
Van Schaftingen E; Jaeken J
FEBS Lett; 1995 Dec; 377(3):318-20. PubMed ID: 8549746
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib.
de Lonlay P; Seta N
Biochim Biophys Acta; 2009 Sep; 1792(9):841-3. PubMed ID: 19101627
[TBL] [Abstract][Full Text] [Related]
12. A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations.
Assmann B; Hackler R; Peters V; Schaefer JR; Arndt T; Mayatepek E; Jaeken J; Hoffmann GF
Neuropediatrics; 2001 Dec; 32(6):313-8. PubMed ID: 11870587
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis.
Grünewald S; Imbach T; Huijben K; Rubio-Gozalbo ME; Verrips A; de Klerk JB; Stroink H; de Rijk-van Andel JF; Van Hove JL; Wendel U; Matthijs G; Hennet T; Jaeken J; Wevers RA
Ann Neurol; 2000 Jun; 47(6):776-81. PubMed ID: 10852543
[TBL] [Abstract][Full Text] [Related]
14. A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation.
Chu J; Mir A; Gao N; Rosa S; Monson C; Sharma V; Steet R; Freeze HH; Lehrman MA; Sadler KC
Dis Model Mech; 2013 Jan; 6(1):95-105. PubMed ID: 22899857
[TBL] [Abstract][Full Text] [Related]
15. [Congenital disorder of glycosylation type 1b. Experience with mannose treatment].
Martín Hernández E; Vega Pajares AI; Pérez González B; Ecay Crespo MJ; Leal Pérez F; Manzanares López-Manzanares J; Ugarte Pérez M; Pérez-Cerdá Silvestre C
An Pediatr (Barc); 2008 Oct; 69(4):358-65. PubMed ID: 18928705
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig.
Eklund EA; Newell JW; Sun L; Seo NS; Alper G; Willert J; Freeze HH
Mol Genet Metab; 2005 Jan; 84(1):25-31. PubMed ID: 15639192
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose.
Hendriksz CJ; McClean P; Henderson MJ; Keir DG; Worthington VC; Imtiaz F; Schollen E; Matthijs G; Winchester BG
Arch Dis Child; 2001 Oct; 85(4):339-40. PubMed ID: 11567948
[TBL] [Abstract][Full Text] [Related]
18. Congenital disorders of glycosylation type Ia and Ib. Genetic, biochemical and clinical studies.
Kjaergaard S
Dan Med Bull; 2004 Nov; 51(4):350-63. PubMed ID: 16009061
[No Abstract] [Full Text] [Related]
19. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
20. Long term outcome of MPI-CDG patients on D-mannose therapy.
Girard M; Douillard C; Debray D; Lacaille F; Schiff M; Vuillaumier-Barrot S; Dupré T; Fabre M; Damaj L; Kuster A; Torre S; Mention K; McLin V; Dobbelaere D; Borgel D; Bauchard E; Seta N; Bruneel A; De Lonlay P
J Inherit Metab Dis; 2020 Nov; 43(6):1360-1369. PubMed ID: 33098580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
